Luis M. Vilá to Cyclophosphamide
This is a "connection" page, showing publications Luis M. Vilá has written about Cyclophosphamide.
Connection Strength
1.296
-
Santiago-Casas Y, Peredo RA, Vil? LM. Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain-Barre syndrome-like acute axonal neuropathies: report of two cases. Lupus. 2013 Mar; 22(3):324-7.
Score: 0.393
-
Castro-Santana LE, Col?n M, Molina MJ, Rodr?guez VE, Mayor AM, Vil? LM. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose. Ethn Dis. 2010; 20(1 Suppl 1):S1-116-21.
Score: 0.316
-
Gonz?lez-Mel?ndez A, Medina-Parrilla EJ, V?lez R, Vil? LM. Isolated intestinal polyarteritis nodosa in an elderly patient. BMJ Case Rep. 2021 Mar 04; 14(3).
Score: 0.171
-
Gago R, Shum LM, Vil? LM. Right upper quadrant abdominal pain as the initial presentation of polyarteritis nodosa. BMJ Case Rep. 2017 Feb 22; 2017.
Score: 0.129
-
Rodr?guez-P?rez N, Rodr?guez-Navedo Y, Font YM, Vil? LM. Inflammatory myopathy as the initial presentation of cryoglobulinaemic vasculitis. BMJ Case Rep. 2013 Jun 03; 2013.
Score: 0.100
-
L?pez-L?pez L, Rivera-Rodr?guez N, Vil? LM. Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep. 2012 Sep 12; 2012.
Score: 0.095
-
Gonz?lez LA, Pons-Estel GJ, Zhang JS, McGwin G, Roseman J, Reveille JD, Vil? LM, Alarc?n GS. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus. 2009 Feb; 18(2):184-6.
Score: 0.074
-
Gonz?lez LA, McGwin G, Dur?n S, Pons-Estel GJ, Apte M, Vil? LM, Reveille JD, Alarc?n GS. Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII). Ann Rheum Dis. 2008 Aug; 67(8):1170-3.
Score: 0.017